G1 Therapeutics

205 articles about G1 Therapeutics

• University of North Carolina Spinout G1 Therapeutics Locks in $47 Million Series C Financing

  5/12/2016

• G1 Therapeutics To Present At The 18th Annual BIO CEO & Investor Conference

  2/2/2016

• G1 Therapeutics To Present At The Stifel 2015 Healthcare Conference

  11/10/2015

• Glenn P. Muir Appointed To G1 Therapeutics Board Of Directors

  10/21/2015

• G1 Therapeutics To Present At September Biotech Conferences

  9/3/2015

• G1 Therapeutics Announces Initiation Of Two Phase Ib/IIa Trials Of CDK4/6 Inhibitor G1T28 In Small-Cell Lung Cancer

  8/11/2015

• G1 Therapeutics To Present At August Investor Conferences

  8/5/2015

• G1 Therapeutics To Present At The BIO International Convention

  6/10/2015

• G1 Therapeutics Announces Positive Phase Ia Data For CDK4/6 Inhibitor G1T28

  5/27/2015

• G1 Therapeutics To Present New Data On CDK4/6 Inhibitor G1T28 At The 2015 ASCO Annual Meeting

  5/14/2015

• G1 Therapeutics To Present New Data On CDK4/6 Inhibitor G1T28 At The American Association for Cancer Research Annual Meeting

  4/16/2015

• G1 Therapeutics To Present At The 14th Annual Needham Healthcare Conference

  4/8/2015

• G1 Therapeutics To Present At 22nd Annual Future Leaders In The Biotech Industry Conference

  3/16/2015

• Tiny Startup G1 Therapeutics Grabs $33 Million to Compete With Big Pharma

  2/6/2015

• G1 Therapeutics To Present At 17th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference

  2/2/2015

• G1 Therapeutics Initiates Phase 1 Clinical Trial Of G1T28-1

  9/11/2014

• G1 Therapeutics Completes Leadership Team With Appointment Of Raj Malik, MD, Chief Medical Officer And Greg Mossinghoff, Chief Business Officer

  6/17/2014

• G1 Therapeutics Brings In A New Chief Executive Officer

  5/20/2014

• G1 Therapeutics To Share New Research Findings At American Association for Cancer Research Annual Meeting 2014

  3/27/2014

• G1 Therapeutics To Present At Biotech Showcase 2014

  1/8/2014